Form 4 Filing for Anuj Gaggar at Assembly Biosciences, Inc.

Anuj Gaggar, Chief Medical Officer at Assembly Biosciences, Inc., was granted 26,000 restricted stock units (RSUs) on March 29, 2026. These RSUs vest in four equal installments through March 29, 2030. The grant represents 65% of Gaggar's annual equity award, with the remaining 35% contingent upon stockholder approval of an amendment to the company's stock incentive plan. Following this grant, Gaggar holds 28,000 shares. This filing also notes the acquisition of 2,000 shares under the employee stock purchase plan on November 14, 2025. The transaction code "A" indicates an acquisition, and the price per share was $0.0, typical for equity awards.